Note 11 - Segment Information (Details Textual) |
12 Months Ended | ||
---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Number of Reportable Segments | 3 | ||
Biotechnology [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member] | |||
Number of Major Customers | 0 | 0 | 0 |
Protein Platforms [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member] | |||
Number of Major Customers | 0 | 0 | |
Diagnostics [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member] | |||
Number of Major Customers | 1 | 0 | 1 |
Diagnostics [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member] | One Customer [Member] | |||
Concentration Risk, Percentage | 12.00% | 13.00% |
X | ||||||||||
- Definition Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|